| Title | Description | Host | Host Type | Outcomes |
|---|---|---|---|---|
| AMU Policy Change: Incentive Tools to Reduce AMU of Critically Important Antimicrobials | Before (2014) vs after (2016) incentive tools for reducing AMU of critically important antimicrobials, i.e. prohibition on discounts, rebates, reductions (in effect Jan 1 2015). High level resistance (> 1 ug/mL: clinical breakpoint). Caecal sample @ abatt | Turkey | Not Specified | 1 |
| AMU Policy Change: Incentive Tools to Reduce AMU of Critically Important Antimicrobials | Before (2014) vs after (2016) incentive tools for reducing AMU of critically important antimicrobials, i.e. prohibition on discounts, rebates, reductions (in effect Jan 1 2015). Non-wild-type (ECOFF) considered resistant. Caecal sample @ abattoir (host su | Turkey | Not Specified | 6 |
| AMU Policy Changes: Incentive Tools to Reduce AMU of Critically Important Antimicrobials (CIAs) & Ban of Preventive Use of CIAs | Before (2014) vs after (2018) incentive tools for reducing AMU of critically important antimicrobials, i.e. prohibition on discounts, rebates, reductions (in effect Jan 1 2015) & ban of preventive CIA use (in effect 2016). High level resistance (> 1 ug/mL | Turkey | Not Specified | 1 |
| AMU Policy Changes: Incentive Tools to Reduce AMU of Critically Important Antimicrobials (CIAs) & Ban of Preventive Use of CIAs | Before (2014) vs after (2018) incentive tools for reducing AMU of critically important antimicrobials, i.e. prohibition on discounts, rebates, reductions (in effect Jan 1 2015) & ban of preventive CIA use (in effect 2016). Non-wild-type (ECOFF) considered | Turkey | Not Specified | 6 |